CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
+60%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+11%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-9.81%
Top 10 Holdings %
Top 10 Hldgs %
63.08%
Holding
35
New
1
Increased
10
Reduced
8
Closed
3
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
$31.4M |
| 2 |
Denali Therapeutics
DNLI
|
$10.5M |
| 3 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$9.65M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$7.01M |
| 5 |
Fulcrum Therapeutics
FULC
|
$6.57M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$83.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
$27.1M |
| 3 |
Q32 Bio
QTTB
|
$14.8M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$14.7M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$12.3M |
Sector Composition
| 1 | Healthcare | 92.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sangamo Therapeutics
SGMO
$157M
| $12.2M | 1.12% | 1,455,000 | – | – |
|
|
ORTX
27
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $11.3M | 1.04% | 820,000 +510,000 | +165% | +$7.01M |
|
28
Twist Bioscience
TWST
$1.63B
| $6.3M | 0.58% | 300,000 | – | – |
|
|
TPTX
29
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.67M | 0.43% | 75,000 | – | – |
|
|
BMY.RT
30
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $4.52M | 0.42% | +1,500,000 | New | +$4.52M |
|
31
Stoke Therapeutics
STOK
$1.08B
| $3.68M | 0.34% | 130,000 | – | – |
|
32
Editas Medicine
EDIT
$231M
| – | – | -415,000 | Closed | -$9.44M |
|
33
Gilead Sciences
GILD
$140B
| – | – | 0 | – | – |
|
|
34
Q32 Bio
QTTB
$20.9M
| – | – | -820,000 | Closed | -$14.8M |
|
|
ONCE
35
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – | -863,300 | Closed | -$83.7M |
|